Fundraising Fox
RebrAIn
Bordeaux, FR · Founded 2021 · 24 employees on LinkedIn · 2 known investors
Find your way into RebrAIn
Sign up to see every warm intro you have to RebrAIn
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RebrAIn team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rebrain provides an AI-driven SaaS platform for planning patient-specific neuromodulation and neurosurgery, aiming to make treatment of neurological and neurodegenerative diseases faster and safer for doctors and patients. It is a spin-off of the University Hospital of Bordeaux and Inria, serving medical centers and neurosurgeons.
Founders & leadership
RebrAIn was founded in 2021 by Emmanuel Cuny and Nejib Zemzemi.
EC
Emmanuel CunyCo-founder, CMO & Board PresidentFunctional neurosurgeon with clinical practice since the early 1990s focused on movement disorders and pain, and researcher at INRIA who spent 10 years developing a surgical targeting model with Nejib Zemzemi. Co-founder and Chief Medical Officer of RebrAIn, a spin-off platform for AI-driven neuromodulation planning that has supported over 1,000 brain targeting procedures across European and U.S. centers.
NZ
Nejib ZemzemiCo-founder, CSO & CTO
DC
David CaumartinCEODavid Caumartin spent 15 years at GE Healthcare in medical imaging, including management of a $350M global business, before serving as CEO of Theraclion, a Euronext-listed company that developed focused ultrasound technology and treated thousands of patients. He is now CEO of RebrAIn, an FDA-cleared neurosurgery planning software company based in Bordeaux.
Investors · 2
Frequently asked questions
- What does RebrAIn do?
- Rebrain provides an AI-driven SaaS platform for planning patient-specific neuromodulation and neurosurgery, aiming to make treatment of neurological and neurodegenerative diseases faster and safer for doctors and patients. It is a spin-off of the University Hospital of Bordeaux and Inria, serving medical centers and neurosurgeons.
- Who founded RebrAIn?
- RebrAIn was founded by Emmanuel Cuny, Nejib Zemzemi in 2021.
- Who are RebrAIn's investors?
- RebrAIn's investors include Karista, CapDecisif Management.
- Where is RebrAIn headquartered?
- RebrAIn is headquartered in Bordeaux, FR.